Entinostat (MS-275) induces growth arrest and apoptosis in AML cell lines and patient samples by inhibiting the antiapoptotic proteins Bcl-2 and Mcl-1, as well as via p21 increase. Here, CDKN1A is linked to acute myeloid leukemia.